Patients' and families' home care service priorities

患者和家属的家庭护理服务优先事项

基本信息

  • 批准号:
    6918391
  • 负责人:
  • 金额:
    $ 40.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-08-01 至 2008-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Patients with cancer and their families have substantial needs for care, including needs for symptom control, spiritual support, emotional and psychological support, and practical assistance. For patients with advanced cancer whose goals focus exclusively on comfort care, hospice offers a widely utilized mechanism for meeting these needs. However, hospice is not an option for patients as long as they continue to pursue disease-modifying cancer treatment. Instead, patients with cancer typically enroll in hospice very late in the course of illness. These patients, and their families, benefit from hospice services only briefly. For this reason, there is rapidly growing interest in supportive home care programs as an "upstream" alternative to hospice for patients who are still seeking disease-modifying treatment. These programs are designed to meet the supportive care needs of patients with cancer and their families before they are eligible to enroll in hospice. These programs offer a promising mechanism for providing supportive care earlier in the illness course. However, it is not known what program services are most important to patients and their families. Nor is it known whether subgroups of patients and families share distinct needs for care and preferences for treatment and may thus prefer unique combinations of services. It is essential to define patients' and families' preferences about supportive home care services in order to design programs that optimally meet patients' and families' needs. The goal of this Project is to define the supportive home care services that are most valuable to patients with cancer and their families and to define subgroups of patients and families with unique priorities.
描述(由申请人提供):癌症患者及其家人有大量的护理需求,包括症状控制,精神支持,情感和心理支持以及实际援助的需求。对于晚期癌症患者,其目标完全集中在舒适护理,临终关怀提供了一个广泛使用的机制,以满足这些需求。然而,临终关怀不是一个选择的病人,只要他们继续追求疾病修饰癌症治疗。相反,癌症患者通常在疾病过程中很晚才参加临终关怀。这些病人和他们的家人只能短暂地从临终关怀服务中受益。出于这个原因,人们对支持性家庭护理计划的兴趣迅速增长,作为仍在寻求疾病改善治疗的患者的临终关怀的“上游”替代方案。这些计划旨在满足癌症患者及其家人在有资格参加临终关怀之前的支持性护理需求。这些方案提供了一个有希望的机制,在疾病过程的早期提供支持性护理。然而,目前尚不清楚哪些项目服务对患者及其家属最重要。也不知道患者和家庭的亚组是否有不同的护理需求和治疗偏好,因此可能更喜欢独特的服务组合。确定患者和家庭对支持性家庭护理服务的偏好,以设计最佳满足患者和家庭需求的方案至关重要。本项目的目标是确定对癌症患者及其家庭最有价值的支持性家庭护理服务,并确定具有独特优先事项的患者和家庭亚组。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID J CASARETT其他文献

DAVID J CASARETT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID J CASARETT', 18)}}的其他基金

CHOICE: Coalition of Hospices Organized to Investigate Comparative Effectiveness
CHOICE:组织临终关怀联盟调查比较有效性
  • 批准号:
    8541805
  • 财政年份:
    2012
  • 资助金额:
    $ 40.36万
  • 项目类别:
CHOICE: Coalition of Hospices Organized to Investigate Comparative Effectiveness
CHOICE:组织临终关怀联盟调查比较有效性
  • 批准号:
    8427701
  • 财政年份:
    2012
  • 资助金额:
    $ 40.36万
  • 项目类别:
Patients' and families' home care service priorities
患者和家属的家庭护理服务优先事项
  • 批准号:
    7250234
  • 财政年份:
    2005
  • 资助金额:
    $ 40.36万
  • 项目类别:
Patients' and families' home care service priorities
患者和家属的家庭护理服务优先事项
  • 批准号:
    7098905
  • 财政年份:
    2005
  • 资助金额:
    $ 40.36万
  • 项目类别:
PATIENT PREFERENCES ABOUT END OF LIFE RESEARCH
患者对临终研究的偏好
  • 批准号:
    6046063
  • 财政年份:
    2000
  • 资助金额:
    $ 40.36万
  • 项目类别:

相似海外基金

Biomedical Research Core 3 - Clinical Research Core
生物医学研究核心 3 - 临床研究核心
  • 批准号:
    10059768
  • 财政年份:
    2020
  • 资助金额:
    $ 40.36万
  • 项目类别:
Biomedical Research Core 3 - Clinical Research Core
生物医学研究核心 3 - 临床研究核心
  • 批准号:
    10214616
  • 财政年份:
    2020
  • 资助金额:
    $ 40.36万
  • 项目类别:
Biomedical Research Core 3 - Clinical Research Core
生物医学研究核心 3 - 临床研究核心
  • 批准号:
    10686076
  • 财政年份:
    2020
  • 资助金额:
    $ 40.36万
  • 项目类别:
Novel Approaches to Identifying and Engaging Disadvantaged Patients with Alzheimer’s Disease (AD) in Clinical Research
识别弱势阿尔茨海默病 (AD) 患者并使之参与临床研究的新方法
  • 批准号:
    9770763
  • 财政年份:
    2018
  • 资助金额:
    $ 40.36万
  • 项目类别:
Novel Approaches to Identifying and Engaging Disadvantaged Patients with Alzheimer’s Disease (AD) in Clinical Research
识别弱势阿尔茨海默病 (AD) 患者并使之参与临床研究的新方法
  • 批准号:
    10228043
  • 财政年份:
    2018
  • 资助金额:
    $ 40.36万
  • 项目类别:
Novel Approaches to Identifying and Engaging Disadvantaged Patients with Alzheimer’s Disease (AD) in Clinical Research
识别弱势阿尔茨海默病 (AD) 患者并使之参与临床研究的新方法
  • 批准号:
    10448269
  • 财政年份:
    2018
  • 资助金额:
    $ 40.36万
  • 项目类别:
Novel Approaches to Identifying and Engaging Disadvantaged Patients with Alzheimer’s Disease (AD) in Clinical Research
识别弱势阿尔茨海默病 (AD) 患者并使之参与临床研究的新方法
  • 批准号:
    9977895
  • 财政年份:
    2018
  • 资助金额:
    $ 40.36万
  • 项目类别:
Tenth Cooley's Anemia Symposium: Basic Science, Clinical Research, and Patient Healthcare for Thalassemia Syndromes.
第十届库利贫血研讨会:地中海贫血综合征的基础科学、临床研究和患者保健。
  • 批准号:
    8986370
  • 财政年份:
    2015
  • 资助金额:
    $ 40.36万
  • 项目类别:
Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe)
ALS 及相关疾病的临床研究以促进治疗开发 (CReATe)
  • 批准号:
    10020808
  • 财政年份:
    2014
  • 资助金额:
    $ 40.36万
  • 项目类别:
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Administrative Core
ALS 临床研究
  • 批准号:
    10687072
  • 财政年份:
    2014
  • 资助金额:
    $ 40.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了